Transforming growth factor‐beta1 affects interleukin‐10 production in the bone marrow of patients with chronic idiopathic neutropenia

Katerina Pyrovolaki(University of Crete), Helen Α. Papadaki(University of Crete), G. Gvazava(University of Crete), Maria Ximeri(University of Crete), Maria Velegraki(The Ohio State University), Christina Kalpadakis(University of Crete), Irene Mavroudi(University of Crete), Mirjam Klaus(Praxis für Humangenetik), George D. Eliopoulos(University of Crete), N. Papadantonakis(University of Crete)
European Journal Of Haematology
August 28, 2007
10.1111/j.1600-0609.2007.00961.x
Cited by 4

Related Papers

Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2
|Nature Genetics|2003|389
Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti–tumor necrosis factor-α antibody therapy
|Blood|2002|266
Baraitser–Winter cerebrofrontofacial syndrome: delineation of the spectrum in 42 cases
|European Journal of Human Genetics|2014|174
Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis
|Annals of the Rheumatic Diseases|2007|154
Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha–mediated effect
|Blood|2002|138